Organizations Filed Purposes:
CANCER COMMONS AIMS TO ENSURE THAT PATIENTS AND THEIR PHYSICIANS HAVE THE KNOWLEDGE THEY NEED TO MAKE THE BEST POSSIBLE PERSONALIZED TREATMENT DECISIONS, AND TO CONTINUOUSLY UPDATE THAT KNOWLEDGE BASED ON EACH PATIENT'S RESPONSE.
CANCER COMMONS, BY DESIGN, IS A NEUTRAL, PATIENT-CENTRIC NON-PROFIT CLEARINGHOUSE THAT ENCOURAGES KNOWLEDGE AND DATA SHARING BY INDIVIDUAL PATIENTS AND PHYSICIANS AS WELL AS NON-PROFIT, COMMERCIAL, AND GOVERNMENT ENTITIES. WE USE INFORMATION TECHNOLOGY, ARTIFICIAL INTELLIGENCE (AI), AND CROWDSOURCING TO HELP PATIENTS AND PHYSICIANS MAKE THE BEST POSSIBLE DECISIONS, AND CONTINUALLY LEARN FROM EACH PATIENT'S RESULTS.
PATIENT SERVICES: ALL CANCERS (EXCEPT BRAIN & PANCREATIC) KNOWLEDGEABLE SCIENTISTS AND EXPERT PHYSICIANS PROVIDE CANCER PATIENTS WITH EDUCATION AND INFORMATION TO HELP THEM NAVIGATE CANCER TREATMENT. PATIENTS RECEIVE PERSONALIZED SERVICES THAT MAY INCLUDE CASE-SPECIFIC RESOURCES AND INFORMATION, INDIVIDUALIZED TREATMENT OPTIONS, AND SUPPORT IN ACCESSING THOSE OPTIONS. PATIENT PROGRESS IS TRACKED TO PROVIDE MID-COURSE CORRECTIONS AND IMPROVE SERVICES FOR FUTURE PATIENTS. ACCOMPLISHMENTS:THIS YEAR, OUR WEB-BASED PATIENT SERVICE RESPONDED TO INQUIRIES FROM NEARLY 1,000 NEW PATIENTS. OVER 80% OF PATIENTS WERE MATCHED WITH RELEVANT CLINICAL TRIALS, AND 70% ENGAGED THROUGHOUT THEIR CANCER JOURNEY. OVER THE PAST DECADE, WE HAVE HAD CLOSE TO 25,000 INTERACTIONS WITH OVER 4000 PATIENTS AND THEIR CAREGIVERS, IN 69 COUNTRIES.
PATIENT SERVICES: PANCREATIC CANCER PROGRAM: NOVEL TREATMENT OPTIONS FOR ADVANCED PANCREATIC CANCER PATIENTS PATIENT CASES ARE VETTED THROUGH VIRTUAL TUMOR BOARDS. THE VIRTUAL TUMOR BOARDS ARE COMPRISED OF INTERNAL PHD STAFF SCIENTISTS, AUGMENTED BY A NETWORK OF NATIONALLY-RECOGNIZED PANCREATIC CANCER EXPERTS INCLUDING ONCOLOGISTS, RADIATION ONCOLOGISTS, SURGEONS, AND CLINICAL SCIENTISTS. THESE EXPERTS PROVIDE FEEDBACK ON CURRENT TREATMENT PLANS, AND RATIONALES FOR CONSIDERING NOVEL TESTING AND TREATMENT OPTIONS THROUGH A COLLECTIVE REASONING PROCESS. PATIENTS ARE PROVIDED WITH A COMPREHENSIVE REPORT TO DISCUSS WITH THEIR TREATING PHYSICIAN. PATIENTS ARE THEN CONTINUOUSLY MONITORED TO LEARN WHAT THEY DID AND HOW WELL IT IS WORKING. ADDITIONALLY, CANCER COMMONS HELPS FACILITATE ACCESS TO INVESTIGATIONAL AND OFF-LABEL THERAPIES, THROUGH EXPANDED ACCESS PROGRAMS AND REIMBURSEMENT SUPPORT. ACCOMPLISHMENTS: DURING FISCAL YEAR 19 27 PANCREATIC CANCER PATIENTS PARTICIPATED IN THIS PROGRAM.
Executives Listed on Filing
Total Salary includes financial earnings, benefits, and all related organization earnings listed on tax filing
| Name | Title | Hours Per Week | Total Salary |
|---|
| Erika Monteverdi | EXECUTIVE DIRECTOR | 30 | $172,576 |
| Emilya Shtivelman | CHIEF SCIENTIST | 33 | $129,000 |
| Masako Yokota | SECRETARY | 40 | $86,978 |
| Martha Dehnow Through 103118 | CFO | 30 | $42,790 |
| Frank Mccormick Through 53119 | DIRECTOR | 1 | $0 |
| Shelley Frisbie | CFO | 1 | $0 |
| Laurence Marton | DIRECTOR | 2 | $0 |
| Jay M Tenenbaum | CHAIR, DIRECTOR, PRESIDENT | 20 | $0 |
| Heather Rangel | DIRECTOR | 1 | $0 |
| Gladys Monroy | DIRECTOR | 2 | $0 |
| Edward Staren | DIRECTOR | 1 | $0 |
| Dick Levy | DIRECTOR | 2 | $0 |
| Ajit Singh | DIRECTOR | 1 | $0 |
Data for this page was sourced from XML published by IRS (
public 990 form dataset) from:
https://s3.amazonaws.com/irs-form-990/202031969349306153_public.xml